MARKET

BLRX

BLRX

Biolinerx
NASDAQ
0.6211
-0.0079
-1.25%
Closed 15:59 09/13 EDT
OPEN
0.6300
PREV CLOSE
0.6290
HIGH
0.6440
LOW
0.6113
VOLUME
166.55K
TURNOVER
--
52 WEEK HIGH
2.530
52 WEEK LOW
0.5100
MARKET CAP
49.65M
P/E (TTM)
-0.8142
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BLRX last week (0902-0906)?
Weekly Report · 4d ago
BioLine RX Initiated at Buy by Jones Trading
Dow Jones · 09/04 16:15
BioLine RX Price Target Announced at $2.00/Share by Jones Trading
Dow Jones · 09/04 16:15
Jones Trading Initiates Coverage On BioLine Rx with Buy Rating, Announces Price Target of $2
Benzinga · 09/04 16:06
Buy Rating Affirmed for Bioline RX Ltd on FDA Approval and Market Expansion Potential
TipRanks · 09/03 20:25
Weekly Report: what happened at BLRX last week (0826-0830)?
Weekly Report · 09/02 10:21
Weekly Report: what happened at BLRX last week (0819-0823)?
Weekly Report · 08/26 10:20
BioLineRx Schedules Annual Shareholders Meeting
TipRanks · 08/19 20:57
More
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Webull offers BioLine RX Ltd - ADR stock information, including NASDAQ: BLRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLRX stock methods without spending real money on the virtual paper trading platform.